Dermapharm Holding SE buy Snowman
Start price
16.06.21
/
50%
€71.65
Target price
16.06.22
€86.00
Performance (%)
-30.50%
End price
20.05.22
€49.80
Summary
This prediction ended on 20.05.22 with a price of €49.80. The BUY prediction by Snowman for Dermapharm Holding SE performed very badly with a performance of -30.50%. Snowman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 1.615% | 1.615% | -1.178% | -4.430% |
| iShares Core DAX® | 1.659% | 1.586% | 18.113% | 65.562% |
| iShares Nasdaq 100 | 0.381% | 1.900% | 8.877% | 103.178% |
| iShares Nikkei 225® | 2.102% | -1.377% | 13.281% | 43.551% |
| iShares S&P 500 | 0.221% | 1.258% | 3.556% | 63.162% |
Comments by Snowman for this prediction
In the thread Dermapharm Holding SE diskutieren
Kursziel geändert auf 86,0